President Donald Trump announced two new drug-pricing rules Nov. 20, one that would link Medicare Part B drug prices to those paid in other countries and one to eliminate rebates drugmakers pay to pharmacy benefit managers, The Hill reported. 

Companies most often cited the cost of COVID-19 testing as the primary reason they weren't testing their workers, rather than test availability or turnaround times, The New York Times reported. 

Here are some of the recent leadership changes affecting health IT:

The U.S. Department of Agriculture granted the Georgia Cancer Center at Augusta University $576,035 Nov. 19 to expand access to skin cancer care, particularly for melanoma, in the state. 

About 34 percent of Minnesota's 87 counties had at least one COVID-19 case epidemiologically linked to the 10-day August motorcycle rally in Sturgis, S.D., the CDC said in a Nov. 20 report.

Healthcare communication professionals should deploy messaging that encourages vaccine acceptance because the success of the country's vaccination effort hinges on Americans' willingness to be inoculated, according to a study published Nov. 19 in Health Affairs.

LSU Health Care Services Division reported that an unauthorized party accessed an employee's email account and compromised patient information, according to a report in The Daily Advertiser.

James Kehoe, Walgreens Boots Alliance's global CFO, expressed little concern about Amazon's recent entry into pharmacy Nov. 19 when he spoke at the Wolfe Healthcare Conference, according to Bloomberg.

Medical device and drug recalls, whether voluntary or mandated by the FDA, ensure patient safety. Here are five reported to the FDA since the end of October:

Fresenius Kabi is recalling one lot of its sedative drug, dexmedetomidine, after finding it contains trace amounts of lidocaine, an anesthetic. 

Two Walmart Health centers opened in Chicago Nov. 20 adjacent to newly remodeled Walmart supercenters. 

From Kaiser Permanente settling false claims allegations to a Montana health system sued over an oncologist's sudden absence, here are the latest healthcare industry lawsuits and settlements making headlines. 

Out of 817 elderly patients with COVID-19 who went to the emergency department, 28 percent (226) had delirium upon arrival, according to a study published Nov. 19 in JAMA Network Open. 

About 34 percent of young adults who completed a research survey said they've changed their vaping or substance use patterns in response to the pandemic, according to a Rochester, Minn.-based Mayo Clinic report published in Sage Open Medicine. 

The FDA has granted emergency authorization for Eli Lilly's drug, Olumiant, in combination with Gilead's remdesivir as a treatment for hospitalized COVID-19 patients, Eli Lilly said Nov. 19. 

Pfizer submitted an application for an emergency use authorization of its COVID-19 vaccine candidate to the FDA Nov. 20.

Hospitalized COVID-19 patients face a 22 percent higher risk of developing sepsis and are 113 percent more likely to experience septic shock compared to hospitalized influenza patients, according to an Epic Health Research Network report published Nov. 19. 

The World Health Organization on Nov. 20 recommended patients not be given remdesivir to treat COVID-19, saying there is no evidence that the antiviral drug improves patients' disease severity or mortality rates.

The following leadership moves by women have been reported since Nov. 13.

The following hospital and health system executive moves have been reported since Nov. 13: